Back to Article:

Drug plan considerations during the coronavirus pandemic

Add a comment

Have your say on this topic! Comments that are thought to be disrespectful or offensive may be removed by our Benefits Canada admins. Thanks!

* These fields are required.
Field required
Field required
Field required
Comments

David Hartig:

Since there are no drugs for Covid-19, it would appear the impact on availability of other drugs should be minimally affected. It’s more likely plan sponsors are concerned that potential layoffs of employees could result in everyone topping up their needed drugs prior to the layoff happening.

Monday, April 20 at 12:36 pm | Reply

Join us on Twitter